BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1132 related articles for article (PubMed ID: 31401742)

  • 1. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value.
    Pellicori P; Zhang J; Lukaschuk E; Joseph AC; Bourantas CV; Loh H; Bragadeesh T; Clark AL; Cleland JG
    Eur Heart J; 2015 Mar; 36(12):733-42. PubMed ID: 25336215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent atrial fibrillation in heart failure with preserved ejection fraction: Prognostic relevance and association with clinical, imaging and invasive haemodynamic parameters.
    Schönbauer R; Duca F; Kammerlander AA; Aschauer S; Binder C; Zotter-Tufaro C; Koschutnik M; Fiedler L; Roithinger FX; Loewe C; Hengstenberg C; Bonderman D; Mascherbauer J
    Eur J Clin Invest; 2020 Feb; 50(2):e13184. PubMed ID: 31732964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D deficiency in patients with diastolic dysfunction or heart failure with preserved ejection fraction.
    Nolte K; Herrmann-Lingen C; Platschek L; Holzendorf V; Pilz S; Tomaschitz A; Düngen HD; Angermann CE; Hasenfuß G; Pieske B; Wachter R; Edelmann F
    ESC Heart Fail; 2019 Apr; 6(2):262-270. PubMed ID: 30784226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Minimal Left Atrial Volume in Heart Failure With Preserved Ejection Fraction.
    Shin SH; Claggett B; Inciardi RM; Santos ABS; Shah SJ; Zile MR; Pfeffer MA; Shah AM; Solomon SD
    J Am Heart Assoc; 2021 Aug; 10(15):e019545. PubMed ID: 34325519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction.
    Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV
    Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicardial fat in heart failure patients with mid-range and preserved ejection fraction.
    van Woerden G; Gorter TM; Westenbrink BD; Willems TP; van Veldhuisen DJ; Rienstra M
    Eur J Heart Fail; 2018 Nov; 20(11):1559-1566. PubMed ID: 30070041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term prognostic impact of left atrial volumes and emptying fraction in a community-based cohort.
    Hedberg P; Selmeryd J; Leppert J; Henriksen E
    Heart; 2017 May; 103(9):687-693. PubMed ID: 28067203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial function, atrial volume and cardiovascular clinical outcomes in patients with end-stage renal disease - A study of cardiac computed tomography.
    Dupont L; Winther S; Jørgensen HS; Bomholt P; Bøtker HE; Bøttcher M; Ivarsen P; Svensson M
    J Cardiovasc Comput Tomogr; 2017; 11(5):389-396. PubMed ID: 28705554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.
    Donal E; Lund LH; Oger E; Hage C; Persson H; Reynaud A; Ennezat PV; Bauer F; Drouet E; Linde C; Daubert C;
    Eur J Heart Fail; 2015 Jul; 17(7):680-8. PubMed ID: 26033771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right Atrial Phasic Function in Heart Failure With Preserved and Reduced Ejection Fraction.
    Jain S; Kuriakose D; Edelstein I; Ansari B; Oldland G; Gaddam S; Javaid K; Manaktala P; Lee J; Miller R; Akers SR; Chirinos JA
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1460-1470. PubMed ID: 30343071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Atrial Structure and Function in Heart Failure with Preserved Ejection Fraction: A RELAX Substudy.
    Abbasi SA; Shah RV; McNulty SE; Hernandez AF; Semigran MJ; Lewis GD; Jerosch-Herold M; Kim RJ; Redfield MM; Kwong RY
    PLoS One; 2016; 11(11):e0164914. PubMed ID: 27812147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.